Current oncology reports

https://www.springer.com/journal/11912

1: Larkin R, Hermsen MA, London NR Jr. Translocations and Gene Fusions in Sinonasal Malignancies. Curr Oncol Rep. 2023 Feb 8. doi: 10.1007/s11912-023-01364-x. Epub ahead of print. PMID: 36753024.

2: Bell D, Brandea AI, Hanna EY. Olfactory Neuroblastoma: Morphological Reappraisal and Molecular Insights with Quantum Leap in Clinical Perspectives. Curr Oncol Rep. 2023 Jan;25(1):11-18. doi: 10.1007/s11912-022-01348-3. Epub 2022 Nov 30. PMID: 36449116.

3: Basnet A, Alahmadi A, Gajra A. Older Patients with Lung Cancer: a Summary of Seminal Contributions to Optimal Patient Care. Curr Oncol Rep. 2022 Nov;24(11):1607-1618. doi: 10.1007/s11912-022-01307-y. Epub 2022 Jul 28. PMID: 35900716.

4: Daksla N, Nguyen V, Jin Z, Bergese SD. Brain Prehabilitation for Oncologic Surgery. Curr Oncol Rep. 2022 Nov;24(11):1513-1520. doi: 10.1007/s11912-022-01312-1. Epub 2022 Jul 28. PMID: 35900715; PMCID: PMC9606060.

5: Suarez-Meade P, Marenco-Hillembrand L, Sherman WJ. Neuro-oncologic Emergencies. Curr Oncol Rep. 2022 Aug;24(8):975-984. doi: 10.1007/s11912-022-01259-3. Epub 2022 Mar 30. PMID: 35353348.

6: Caulfield JI, Kluger HM. Emerging Studies of Melanoma Brain Metastasis. Curr Oncol Rep. 2022 May;24(5):585-594. doi: 10.1007/s11912-022-01237-9. Epub 2022 Feb 25. PMID: 35212922.

7: Crooms RC, Johnson MO, Leeper H, Mehta A, McWhirter M, Sharma A. Easing the Journey-an Updated Review of Palliative Care for the Patient with High-Grade Glioma. Curr Oncol Rep. 2022 Apr;24(4):501-515. doi: 10.1007/s11912-022-01210-6. Epub 2022 Feb 22. PMID: 35192120.

8: Mathis NJ, Wijetunga NA, Imber BS, Pike LRG, Yang JT. Recent Advances and Applications of Radiation Therapy for Brain Metastases. Curr Oncol Rep. 2022 Mar;24(3):335-342. doi: 10.1007/s11912-022-01209-z. Epub 2022 Feb 8. PMID: 35133614.

9: Waqar M, Trifiletti DM, McBain C, O'Connor J, Coope DJ, Akkari L, Quinones- Hinojosa A, Borst GR. Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature. Curr Oncol Rep. 2022 Mar;24(3):311-324. doi: 10.1007/s11912-021-01157-0. Epub 2022 Feb 4. PMID: 35119629; PMCID: PMC8885508.

10: Piña Y, Yadugiri S, Yeboa DN, Ferguson SD, Forsyth PA, Oliva ICG. Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma. Curr Oncol Rep. 2022 Jan;24(1):43-54. doi: 10.1007/s11912-021-01162-3. Epub 2022 Jan 20. PMID: 35059999.

11: Takami H. Advances in Molecular Profiling and Developing Clinical Trials of CNS Germ Cell Tumors: Present and Future Directions. Curr Oncol Rep. 2022 Jan;24(1):105-112. doi: 10.1007/s11912-022-01195-2. Epub 2022 Jan 20. PMID: 35059994.

12: Palussière J, Cazayus M, Cousin S, Cabart M, Chomy F, Catena V, Buy X. Is There a Role for Percutaneous Ablation for Early Stage Lung Cancer? What Is the Evidence? Curr Oncol Rep. 2021 May 5;23(7):81. doi: 10.1007/s11912-021-01072-4. PMID: 33948744.

13: Rivera M, Norman S, Sehgal R, Juthani R. Updates on Surgical Management and Advances for Brain Tumors. Curr Oncol Rep. 2021 Feb 25;23(3):35. doi: 10.1007/s11912-020-01005-7. PMID: 33630180.

14: Dono A, Ballester LY, Primdahl D, Esquenazi Y, Bhatia A. IDH-Mutant Low- grade Glioma: Advances in Molecular Diagnosis, Management, and Future Directions. Curr Oncol Rep. 2021 Jan 25;23(2):20. doi: 10.1007/s11912-020-01006-6. PMID: 33492489.

15: Pant A, Medikonda R, Lim M. Alternative Checkpoints as Targets for Immunotherapy. Curr Oncol Rep. 2020 Nov 3;22(12):126. doi: 10.1007/s11912-020-00983-y. PMID: 33141349; PMCID: PMC7608303.

16: Bunevicius A, Miller J, Parsons M. Isocitrate Dehydrogenase, Patient- Reported Outcomes, and Cognitive Functioning of Glioma Patients: a Systematic Review. Curr Oncol Rep. 2020 Sep 23;22(12):120. doi: 10.1007/s11912-020-00978-9. PMID: 32965568.

17: Lubas MJ, Kumar SS. The Combined Use of SBRT and Immunotherapy-a Literature Review. Curr Oncol Rep. 2020 Sep 15;22(12):117. doi: 10.1007/s11912-020-00986-9. PMID: 32929678.

18: Lütgendorf-Caucig C, Freyschlag C, Masel EK, Marosi C. Guiding Treatment Choices for Elderly Patients with Glioblastoma by a Comprehensive Geriatric Assessment. Curr Oncol Rep. 2020 Jul 10;22(9):93. doi: 10.1007/s11912-020-00951-6. PMID: 32651730; PMCID: PMC7351817.

19: Szalontay L, Khakoo Y. Medulloblastoma: an Old Diagnosis with New Promises. Curr Oncol Rep. 2020 Jul 9;22(9):90. doi: 10.1007/s11912-020-00953-4. PMID: 32643099.

20: Farooqi A, Mitra D, Guadagnolo BA, Bishop AJ. The Evolving Role of Radiation Therapy in Patients with Metastatic Soft Tissue Sarcoma. Curr Oncol Rep. 2020 Jun 29;22(8):79. doi: 10.1007/s11912-020-00936-5. PMID: 32602007.

21: Wierzbicki K, Ravi K, Franson A, Bruzek A, Cantor E, Harris M, Homan MJ, Marini BL, Kawakibi AR, Ravindran R, Teodoro R, Yadav VN, Koschmann C. Correction to: Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma. Curr Oncol Rep. 2020 Apr 16;22(5):47. doi: 10.1007/s11912-020-00912-z. Erratum for: Curr Oncol Rep. 2020 Feb 6;22(2):19. PMID: 32297022.

22: Snyder JM, Pawloski JA, Poisson LM. Developing Real-world Evidence-Ready Datasets: Time for Clinician Engagement. Curr Oncol Rep. 2020 Apr 16;22(5):45. doi: 10.1007/s11912-020-00904-z. PMID: 32297007; PMCID: PMC8214868.

23: Filippiadis DK, Tselikas L, Bazzocchi A, Efthymiou E, Kelekis A, Yevich S. Percutaneous Management of Cancer Pain. Curr Oncol Rep. 2020 Apr 16;22(5):43. doi: 10.1007/s11912-020-00906-x. PMID: 32297006.

24: Parikh BB, Neil EC. Evolving Strategies to Potentially Further Optimize Surgical Interventions in Brain Cancer. Curr Oncol Rep. 2020 Mar 6;22(4):32. doi: 10.1007/s11912-020-0896-x. PMID: 32140793.

25: Wierzbicki K, Ravi K, Franson A, Bruzek A, Cantor E, Harris M, Homan MJ, Marini BL, Kawakibi AR, Ravindran R, Teodoro R, Yadav VN, Koschmann C. Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma. Curr Oncol Rep. 2020 Feb 6;22(2):19. doi: 10.1007/s11912-020-0877-0. Erratum in: Curr Oncol Rep. 2020 Apr 16;22(5):47. PMID: 32030483; PMCID: PMC7501595.

26: Makhlin I, Fox K. Oligometastatic Breast Cancer: Is This a Curable Entity? A Contemporary Review of the Literature. Curr Oncol Rep. 2020 Feb 5;22(2):15. doi: 10.1007/s11912-020-0867-2. PMID: 32025905; PMCID: PMC7219961.

27: Toescu SM, Aquilina K. Current and Emerging Methods of Management of Ependymoma. Curr Oncol Rep. 2019 Jul 29;21(9):78. doi: 10.1007/s11912-019-0826-y. PMID: 31359299.

28: Udovicich C, Phillips C, Kok DL, Tange D, Plumridge NM, Prabhu RS, Haghighi N. Neoadjuvant Stereotactic Radiosurgery: a Further Evolution in the Management of Brain Metastases. Curr Oncol Rep. 2019 Jul 4;21(8):73. doi: 10.1007/s11912-019-0817-z. PMID: 31270629.

29: Ali FS, Arevalo O, Zorofchian S, Patrizz A, Riascos R, Tandon N, Blanco A, Ballester LY, Esquenazi Y. Cerebral Radiation Necrosis: Incidence, Pathogenesis, Diagnostic Challenges, and Future Opportunities. Curr Oncol Rep. 2019 Jun 19;21(8):66. doi: 10.1007/s11912-019-0818-y. PMID: 31218455.

30: Hewins W, Zienius K, Rogers JL, Kerrigan S, Bernstein M, Grant R. The Effects of Brain Tumours upon Medical Decision-Making Capacity. Curr Oncol Rep. 2019 May 2;21(6):55. doi: 10.1007/s11912-019-0793-3. PMID: 31049786; PMCID: PMC6495430.

31: Tanguturi S, Warren LEG. The Current and Evolving Role of Radiation Therapy for Central Nervous System Metastases from Breast Cancer. Curr Oncol Rep. 2019 Apr 16;21(6):50. doi: 10.1007/s11912-019-0803-5. PMID: 30993546.

32: Kothari G, Ost P, Cheung P, Blanchard P, Tree AC, van As NJ, Lo SS, Moghanaki D, Loblaw A, Siva S. Trends in Management of Oligometastatic Hormone- Sensitive Prostate Cancer. Curr Oncol Rep. 2019 Mar 27;21(5):43. doi: 10.1007/s11912-019-0791-5. PMID: 30919165.

33: Fatemi P, Zhang M, Miller KJ, Robe P, Li G. How Intraoperative Tools and Techniques Have Changed the Approach to Brain Tumor Surgery. Curr Oncol Rep. 2018 Sep 26;20(11):89. doi: 10.1007/s11912-018-0723-9. PMID: 30259202.

34: Churilla TM, Weiss SE. Emerging Trends in the Management of Brain Metastases from Non-small Cell Lung Cancer. Curr Oncol Rep. 2018 May 7;20(7):54. doi: 10.1007/s11912-018-0695-9. PMID: 29736685.

35: Johnson E, Dickerson KL, Connolly ID, Hayden Gephart M. Single-Cell RNA- Sequencing in Glioma. Curr Oncol Rep. 2018 Apr 10;20(5):42. doi: 10.1007/s11912-018-0673-2. PMID: 29637300; PMCID: PMC8403493.

36: Jimenez P, Tatsui C, Jessop A, Thosani S, Jimenez C. Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress. Curr Oncol Rep. 2017 Oct 28;19(12):83. doi: 10.1007/s11912-017-0643-0. PMID: 29081018.

37: Ho JC, Phan J. Reirradiation of Skull Base Tumors With Advanced Highly Conformal Techniques. Curr Oncol Rep. 2017 Oct 28;19(12):82. doi: 10.1007/s11912-017-0639-9. PMID: 29080990.

38: Lester-Coll NH, Sher DJ. Cost-Effectiveness of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: a Critical Review. Curr Oncol Rep. 2017 Jun;19(6):41. doi: 10.1007/s11912-017-0599-0. PMID: 28421482.

39: Tan AC, Heimberger AB, Khasraw M. Immune Checkpoint Inhibitors in Gliomas. Curr Oncol Rep. 2017 Apr;19(4):23. doi: 10.1007/s11912-017-0586-5. PMID: 28303490.

40: Rosenberg SA, Baschnagel AM, Bagley SJ, Housri N. Strategies for Translating Evidence-Based Medicine in Lung Cancer into Community Practice. Curr Oncol Rep. 2017 Jan;19(1):5. doi: 10.1007/s11912-017-0563-z. PMID: 28168606.

41: Lin FY, Chintagumpala M. Advances in Management of Pediatric Ependymomas. Curr Oncol Rep. 2015 Oct;17(10):47. doi: 10.1007/s11912-015-0470-0. PMID: 26369328.

42: Videtic GM. The Role of Radiotherapy in Small Cell Lung Cancer: a Revisit. Curr Oncol Rep. 2015 Aug;17(8):37. doi: 10.1007/s11912-015-0458-9. PMID: 26071854.

43: Meyer J, Toomay S. Update on treatment of liver metastases: focus on ablation therapies. Curr Oncol Rep. 2015 Jan;17(1):420. doi: 10.1007/s11912-014-0420-2. PMID: 25416314.

44: Videtic GM. The role of stereotactic radiotherapy in the treatment of oligometastases. Curr Oncol Rep. 2014 Jul;16(7):391. doi: 10.1007/s11912-014-0391-3. PMID: 24861005.

45: Gorantla V, Kirkwood JM, Tawbi HA. Melanoma brain metastases: an unmet challenge in the era of active therapy. Curr Oncol Rep. 2013 Oct;15(5):483-91. doi: 10.1007/s11912-013-0335-3. PMID: 23954973; PMCID: PMC3801214.

46: Abe E, Aoyama H. The role of whole brain radiation therapy for the management of brain metastases in the era of stereotactic radiosurgery. Curr Oncol Rep. 2012 Feb;14(1):79-84. doi: 10.1007/s11912-011-0201-0. PMID: 22006098.

47: Videtic GM, Stephans KL. The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient? Curr Oncol Rep. 2010 Jul;12(4):235-41. doi: 10.1007/s11912-010-0108-1. PMID: 20446066.

48: Thomas SS, Dunbar EM. Modern multidisciplinary management of brain metastases. Curr Oncol Rep. 2010 Jan;12(1):34-40. doi: 10.1007/s11912-009-0073-8. PMID: 20425606.

49: Nguyen QN, Chang EL. Emerging role of proton beam radiation therapy for chordoma and chondrosarcoma of the skull base. Curr Oncol Rep. 2008 Jul;10(4):338-43. doi: 10.1007/s11912-008-0052-5. PMID: 18778560.

50: Kupferman ME, Hanna EY. Paragangliomas of the head and neck. Curr Oncol Rep. 2008 Mar;10(2):156-61. doi: 10.1007/s11912-008-0024-9. PMID: 18377829.

51: Majer M, Samlowski WE. Management of metastatic melanoma patients with brain metastases. Curr Oncol Rep. 2007 Sep;9(5):411-6. doi: 10.1007/s11912-007-0056-6. PMID: 17706170.

52: Mody MG, Rao G, Rhines LD. Surgical management of spinal mesenchymal tumors. Curr Oncol Rep. 2006 Jul;8(4):297-304. doi: 10.1007/s11912-006-0036-2. PMID: 17254530.

53: Hegi ME, Stupp R. Correlative studies in neuro-oncology trials: should they influence treatment? Curr Oncol Rep. 2006 Jan;8(1):54-7. doi: 10.1007/s11912-006-0010-z. PMID: 16464404.

54: Taimur S, Edelman MJ. Treatment options for brain metastases in patients with non-small-cell lung cancer. Curr Oncol Rep. 2003 Jul;5(4):342-6. doi: 10.1007/s11912-003-0077-8. PMID: 12781078.

55: Gardner E, Linskey ME, Peñagarícano JA, Hanna EY. Stereotactic radiosurgery for patients with cancer of the head and neck. Curr Oncol Rep. 2003 Mar;5(2):164-9. doi: 10.1007/s11912-003-0105-8. PMID: 12583835.

56: Pollack IF, Biegel J, Yates A, Hamilton R, Finkelstein S. Risk assignment in childhood brain tumors: the emerging role of molecular and biologic classification. Curr Oncol Rep. 2002 Mar;4(2):114-22. doi: 10.1007/s11912-002-0072-5. PMID: 11822983.

57: Flickinger JC. Radiotherapy and radiosurgical management of brain metastases. Curr Oncol Rep. 2001 Nov;3(6):484-9. doi: 10.1007/s11912-001-0069-5. PMID: 11595116.

58: Weinberg JS, Lang FF, Sawaya R. Surgical management of brain metastases. Curr Oncol Rep. 2001 Nov;3(6):476-83. doi: 10.1007/s11912-001-0068-6. PMID: 11595115.

59: Gilbert MR. Brain metastases: still an 'orphan' disease? Curr Oncol Rep. 2001 Nov;3(6):463-6. doi: 10.1007/s11912-001-0066-8. PMID: 11595113.

60: Gilbert MR. Brain tumor clinical trials: pitfalls and promise for the future. Curr Oncol Rep. 2000 Nov;2(6):473-5. doi: 10.1007/s11912-000-0095-8. PMID: 11122880.

61: Bansal K, Engelhard HH. Gene therapy for brain tumors. Curr Oncol Rep. 2000 Sep;2(5):463-72. doi: 10.1007/s11912-000-0067-z. PMID: 11122879.

62: Linskey ME. Multi-agent cytostatic treatment of 'low-grade' gliomas. Curr Oncol Rep. 2000 Sep;2(5):454-62. doi: 10.1007/s11912-000-0066-0. PMID: 11122878.

63: Mehta MP, Tomé WA, Olivera GH. Radiotherapy for brain tumors. Curr Oncol Rep. 2000 Sep;2(5):438-44. doi: 10.1007/s11912-000-0064-2. PMID: 11122876.

64: Olson JJ. Neurosurgical advances in the treatment of brain tumors. Curr Oncol Rep. 2000 Sep;2(5):434-7. doi: 10.1007/s11912-000-0063-3. PMID: 11122875.

65: Takeshima H, Sawamura Y, Gilbert MR, Van Meir EG. Application of advances in molecular biology to the treatment of brain tumors. Curr Oncol Rep. 2000 Sep;2(5):425-33. doi: 10.1007/s11912-000-0062-4. PMID: 11122874.